Boric acid destabilizes the hyphal cytoskeleton and inhibits invasive growth of Candida albicans

Yeast

Volumn 32, Issue 4, 2015, Pages 389-398

  Pointer, Benjamin R ^a   Boyer, Michael P ^a   Schmidt, Martin ^a  

^a DES MOINES UNIVERSITY   (United States)

Author keywords

Boric acid; Candida albicans; Efg1; Tup1; Yeast to hyphae transition

Indexed keywords

BORIC ACID; ANTIFUNGAL AGENT; FUNGAL PROTEIN;

ACID TOLERANCE; ACTIN FILAMENT; ARTICLE; CANDIDA ALBICANS; CELL STRUCTURE; DELETION MUTANT; EFG1 GENE; FLUORESCENCE MICROSCOPY; FUNGUS GROWTH; FUNGUS HYPHAE; GENE; GENE ACTIVATION; GENE DISRUPTION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CYTOSKELETON; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

CANDIDA ALBICANS; FUNGI;

ANTIFUNGAL AGENTS; BORIC ACIDS; CANDIDA ALBICANS; CYTOSKELETON; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HYPHAE;

EID: 84926421567     PISSN: 0749503X     EISSN: 10970061     Source Type: Journal    
DOI: 10.1002/yea.3066     Document Type: Article

References (52)

1. Akashi T, Kanbe T, Tanaka K. 1994. The role of the cytoskeleton in the polarized growth of the germ tube in Candida albicans. Microbiology 140(2): 271-280.
2. Alonso-Monge R, Navarro-Garcia F, Molero G, et al. 1999. Role of the mitogen-activated protein kinase Hog1p in morphogenesis and virulence of Candida albicans. J Bacteriol 181: 3058-3068.
3. Anderson JM, Soll DR. 1986. Differences in actin localization during bud and hypha formation in the yeast Candida albicans. J Gen Microbiol 132: 2035-2047.
4. Bachewich C, Nantel A, Whiteway M. 2005. Cell cycle arrest during S or M phase generates polarized growth via distinct signals in Candida albicans. Mol Microbiol 57: 942-959.
5. Bai C, Xu XL, Wang HS, et al. 2011. Characterization of a hyperactive Cyr1 mutant reveals new regulatory mechanisms for cellular cAMP levels in Candida albicans. Mol Microbiol 82: 879-893.
6. Benderdour M, Hess K, Dzondo-Gadet M, et al. 1998. Boron modulates extracellular matrix and TNFα synthesis in human fibroblasts. Biochem Biophys Res Commun 246: 746-751.
7. Braun BR, Johnson AD. 2000. TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics 155: 57-67.
8. Braun BR, Johnson AD. 1997. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277: 105-109.
9. Braun BR, Kadosh D, Johnson AD. 2001. NRG1, a repressor of filamentous growth in C. albicans, is down-regulated during filament induction. EMBO J 20: 4753-4761.
10. Brittingham A, Wilson WA. 2014. The antimicrobial effect of boric acid on Trichomonas vaginalis. Sex Transm Dis 41: 718-722.
11. Burke D, Dawson D, Stearns T. 2000. Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
12. Calderone RA, Fonzi WA. 2001. Virulence factors of Candida albicans. Trends Microbiol 9: 327-335.
13. Cleveland AA, Farley MM, Harrison LH, et al. 2012. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 55: 1352-1361.
14. Crampin H, Finley K, Gerami-Nejad M, et al. 2005. Candida albicans hyphae have a Spitzenkörper that is distinct from the polarisome found in yeast and pseudohyphae. J Cell Sci 118: 2935-2947.
15. Csank C, Schroppel K, Leberer E, et al. 1998. Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis. Infect Immun 66: 2713-2721.
16. Davis D, Wilson RB, Mitchell AP. 2000. RIM101-dependent and-independent pathways govern pH responses in Candida albicans. Mol Cell Biol 20: 971-978.
17. Davis-Hanna A, Piispanen AE, Stateva LI, et al. 2008. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol 67: 47-62.
18. De Seta F, Schmidt M, Vu B, et al. 2009. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis. J Antimicrob Chemother 63: 325-336.
19. Di Renzo F, Cappelletti G, Broccia ML, et al. 2007. Boric acid inhibits embryonic histone deacetylases: a suggested mechanism to explain boric acid-related teratogenicity. Toxicol Appl Pharmacol 220: 178-185.
20. Epp E, Nazarova E, Regan H, et al. 2013. Clathrin- and Arp2/3-independent endocytosis in the fungal pathogen Candida albicans. MBio 4: e00476-13.
21. Fonzi WA, Irwin MY. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134: 717-728.
22. Gallardo-Williams MT, Maronpot RR, Turner CH, et al. 2003. Effects of boric acid supplementation on bone histomorphometry, metabolism, and biomechanical properties in aged female F-344 rats. Biol Trace Elem Res 93: 155-170.
23. Gerami-Nejad M, Berman J, Gale CA. 2001. Cassettes for PCR-mediated construction of green, yellow and cyan fluorescent protein fusions in Candida albicans. Yeast 18: 859-864.
24. Hazan I, Liu H. 2002. Hyphal tip-associated localization of Cdc42 is F-actin dependent in Candida albicans. Eukaryot Cell 1: 856-864.
25. Homann OR, Dea J, Noble SM, et al. 2009. A phenotypic profile of the Candida albicans regulatory network. PLoS Genet 5: e1000783.
26. Hwang CS, Oh JH, Huh WK, et al. 2003. Ssn6, an important factor of morphological conversion and virulence in Candida albicans. Mol Microbiol 47: 1029-1043.
27. Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME. 2011. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence. J Womens Health (Larchmt) 20: 1245-1255.
28. Ishii T, Matsunaga T, Pellerin P, et al. 1999. The plant cell wall polysaccharide rhamnogalacturonan II self-assembles into a covalently cross-linked dimer. J Biol Chem 274: 13, 098-13, 104.
29. Jacobsen ID, Wilson D, Wachtler B, et al. 2012. Candida albicans dimorphism as a therapeutic target. Expert Rev Anti Infect Ther 10: 85-93.
30. Jones LA, Sudbery PE. 2010. Spitzenkorper, exocyst, and polarisome components in Candida albicans hyphae show different patterns of localization and have distinct dynamic properties. Eukaryot Cell 9: 1455-1465.
31. Kadosh D, Johnson AD. 2001. Rfg1, a protein related to the Saccharomyces cerevisiae hypoxic regulator Rox1, controls filamentous growth and virulence in Candida albicans. Mol Cell Biol 21: 2496-2505.
32. Kebaara BW, Langford ML, Navarathna DH, et al. 2008. Candida albicans Tup1 is involved in farnesol-mediated inhibition of filamentous-growth induction. Eukaryot Cell 7: 980-987.
33. Kim DH, Faull KF, Norris AJ, Eckhert CD. 2004. Borate-nucleotide complex formation depends on charge and phosphorylation state. J Mass Spectrom 39: 743-751.
34. Lane S, Zhou S, Pan T, et al. 2001. The basic helix-loop-helix transcription factor Cph2 regulates hyphal development in Candida albicans partly via TEC1. Mol Cell Biol 21: 6418-6428.
35. Leberer E, Harcus D, Broadbent ID, et al. 1996. Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc Natl Acad Sci U S A 93: 13, 217-13, 222.
36. Leberer E, Harcus D, Dignard D, et al. 2001. Ras links cellular morphogenesis to virulence by regulation of the MAP kinase and cAMP signalling pathways in the pathogenic fungus Candida albicans. Mol Microbiol 42: 673-687.
37. Li CR, Lee RT, Wang YM, et al. 2007. Candida albicans hyphal morphogenesis occurs in Sec3p-independent and Sec3p-dependent phases separated by septin ring formation. J Cell Sci 120: 1898-1907.
38. Liu H, Kohler J, Fink GR. 1994. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266: 1723-1726.
39. Lo HJ, Kohler JR, DiDomenico B, et al. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949.
40. Noble SM, French S, Kohn LA, et al. 2010. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat Genet 42: 590-598.
41. Noble SM, Johnson AD. 2005. Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans. Eukaryot Cell 4: 298-309.
42. Pfaller M, Neofytos D, Diekema D, et al. 2012. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy [PATH Alliance (R)] registry, 2004-2008. Diagn Microbiol Infect Dis 74: 323-331.
43. Pierce JV, Dignard D, Whiteway M, Kumamoto CA. 2013. Normal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes. Eukaryot Cell 12: 37-49.
44. Schmidt M, Schaumberg JZ, Steen CM, Boyer MP. 2010. Boric acid disturbs cell wall synthesis in Saccharomyces cerevisiae. Int J Microbiol 2010: 930465.
45. Schmidt M, Varma A, Drgon T, et al. 2003. Septins, under Cla4p regulation, and the chitin ring are required for neck integrity in budding yeast. Mol Biol Cell 14: 2128-2141.
46. Shi QM, Wang YM, Zheng XD, et al. 2007. Critical role of DNA checkpoints in mediating genotoxic-stress-induced filamentous growth in Candida albicans. Mol Biol Cell 18: 815-826.
47. Smith DA, Nicholls S, Morgan BA, et al. 2004. A conserved stress-activated protein kinase regulates a core stress response in the human pathogen Candida albicans. Mol Biol Cell 15: 4179-4190.
48. Stoldt VR, Sonneborn A, Leuker CE, Ernst JF. 1997. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J 16: 1982-1991.
49. Sudbery PE. 2011. Growth of Candida albicans hyphae. Nat Rev Microbiol 9: 737-748.
50. Swate TE, Weed JC. 1974. Boric acid treatment of vulvovaginal candidiasis. Obstet Gynecol 43: 893-895.
51. Uluisik I, Kaya A, Fomenko DE, et al. 2011. Boron stress activates the general amino acid control mechanism and inhibits protein synthesis. PLoS One 6: e27772.
52. Wilson RB, Davis D, Mitchell AP. 1999. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J Bacteriol 181: 1868-1874.